[go: up one dir, main page]

PE20011260A1 - Derivados de sulfonamida - Google Patents

Derivados de sulfonamida

Info

Publication number
PE20011260A1
PE20011260A1 PE2001000452A PE2001000452A PE20011260A1 PE 20011260 A1 PE20011260 A1 PE 20011260A1 PE 2001000452 A PE2001000452 A PE 2001000452A PE 2001000452 A PE2001000452 A PE 2001000452A PE 20011260 A1 PE20011260 A1 PE 20011260A1
Authority
PE
Peru
Prior art keywords
compound
formula
derivative
refers
procedure
Prior art date
Application number
PE2001000452A
Other languages
English (en)
Inventor
Hamideh Zarrinmayeh
Andrew Hendley Fray
James Abraham Aikins
Dennis Michael Zimmerman
William David Miller
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20011260A1 publication Critical patent/PE20011260A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I Y UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA Ia QUE COMPRENDE: a) NITRAR UNA SULFONAMIDA PARA PROPORCIONAR UN DERIVADO p-NITRO; b) HIDROGENAR EL DERIVADO p-NITRO PARA PROPORCIONAR UN DERIVADO p-AMINO Y c) TRATAR EL DERIVADO p-AMINO CON UN ACIDO ADECUADO, DESPUES CON UNA BASE Y LUEGO CON CLORURO DE 3,5 DIFLUOROBENZOILO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA POTENCIAR LA FUNCION DEL RECEPTOR DE GLUTAMATO ADMINISTRANDO EL COMPUESTO DE FORMULA I PARA EL TRATAMIENTO DE LA DEPRESION, ESQUIZOFRENIA, TRASTORNOS CONGNITVOS
PE2001000452A 2000-05-19 2001-05-18 Derivados de sulfonamida PE20011260A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20582200P 2000-05-19 2000-05-19

Publications (1)

Publication Number Publication Date
PE20011260A1 true PE20011260A1 (es) 2001-12-11

Family

ID=22763775

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000452A PE20011260A1 (es) 2000-05-19 2001-05-18 Derivados de sulfonamida

Country Status (25)

Country Link
US (2) US6720357B2 (es)
EP (1) EP1296944A1 (es)
JP (1) JP2003534315A (es)
KR (1) KR20030007643A (es)
CN (1) CN1429206A (es)
AR (1) AR028590A1 (es)
AU (1) AU2001262936A1 (es)
BR (1) BR0110871A (es)
CA (1) CA2409829A1 (es)
CZ (1) CZ20023796A3 (es)
DZ (1) DZ3344A1 (es)
EA (1) EA004868B1 (es)
EC (1) ECSP014079A (es)
HR (1) HRP20020917A2 (es)
HU (1) HUP0302291A3 (es)
IL (1) IL152154A0 (es)
MX (1) MXPA02010021A (es)
NO (1) NO20025533L (es)
NZ (1) NZ521620A (es)
PE (1) PE20011260A1 (es)
PL (1) PL358184A1 (es)
SK (1) SK16322002A3 (es)
SV (1) SV2002000458A (es)
WO (1) WO2001090056A1 (es)
ZA (1) ZA200208746B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US20040235957A1 (en) * 2001-10-12 2004-11-25 David Bleakman Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (en) * 2003-07-17 2005-02-17 Eli Lilly And Company Combination therapy for treatment of cognitive disorders or psychoses
JP2007521322A (ja) * 2003-09-18 2007-08-02 メルク　エンド　カムパニー　インコーポレーテッド 置換スルホンアミド類
ES2517267T3 (es) 2009-06-26 2014-11-03 Pfizer Inc. Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas
KR101569842B1 (ko) 2009-09-30 2015-11-17 삼성전자 주식회사 텔레비전용 전원공급유닛 및 이를 포함하는 텔레비전
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
MX2015017253A (es) 2013-06-13 2016-04-19 Veroscience Llc Composiciones y metodos para tratar trastornos metabolicos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea
PE20000943A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de sulfonamida
ATE266400T1 (de) 1998-07-31 2004-05-15 Lilly Co Eli Heterocyclyl sulphonamid derivate
US6525099B1 (en) 1998-07-31 2003-02-25 Eli Lilly And Company N-substituted sulfonamide derivatives

Also Published As

Publication number Publication date
US6803484B2 (en) 2004-10-12
US6720357B2 (en) 2004-04-13
ECSP014079A (es) 2002-02-25
KR20030007643A (ko) 2003-01-23
NO20025533L (no) 2003-01-20
PL358184A1 (en) 2004-08-09
HRP20020917A2 (en) 2004-02-29
BR0110871A (pt) 2003-02-11
WO2001090056A1 (en) 2001-11-29
SV2002000458A (es) 2002-10-24
IL152154A0 (en) 2003-05-29
EA004868B1 (ru) 2004-08-26
US20030233015A1 (en) 2003-12-18
NZ521620A (en) 2004-08-27
CZ20023796A3 (cs) 2003-04-16
JP2003534315A (ja) 2003-11-18
HUP0302291A2 (hu) 2003-11-28
MXPA02010021A (es) 2003-02-12
CN1429206A (zh) 2003-07-09
NO20025533D0 (no) 2002-11-18
ZA200208746B (en) 2004-02-10
DZ3344A1 (fr) 2001-11-29
AR028590A1 (es) 2003-05-14
SK16322002A3 (sk) 2003-05-02
AU2001262936A1 (en) 2001-12-03
EP1296944A1 (en) 2003-04-02
EA200201232A1 (ru) 2003-04-24
CA2409829A1 (en) 2001-11-29
HUP0302291A3 (en) 2006-11-28
US20040143020A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
UY27740A1 (es) Nuevos compuestos
UY28150A1 (es) Agentes terapeuticos
PE20070541A1 (es) Compuestos y composiciones que comprenden isoindol-imidas
DE602006012322D1 (de) Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
DK1891038T3 (da) Substituerede n-arylpyrrolidiner som selektive androgenreceptormodulatorer
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
PA8586001A1 (es) Derivados de indol útiles para el tratamiento de enfermedades
GT199800180A (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos.
ECSP941122A (es) Derivados de 5-arilindoles
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
BRPI0415657A (pt) derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c
BR0311494A (pt) Novos indóis substituìdos
UY28144A1 (es) Agentes terapéuticos
BRPI0418245B8 (pt) composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
UY28377A1 (es) Agentes terapeuticos
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BR0314195A (pt) Derivados de piridina substituìda como agentes antitumorais
SE0102055D0 (sv) New Compounds

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed